Clinical Trial Update: Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease [Phase 4]

View source ↗

Summary

A Phase 4 study assessing ophthalmologic safety of long-term pramipexole treatment compared with bromocriptine and other dopamine agonists in Parkinson's diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Bromocriptine (bromocriptine)
• Pramipexole (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Parkinson Disease | Phase 4 | Status: COMPLETED